Calum Leitch's picture

Calum Leitch

Researcher

Department of Clinical Science

E-mailcalum.leitch@uib.no
Visitor Address
Haukeland universitetssykehus, Laboratoriebygget

5009 Bergen
Postal Address
Postboks 7804

5020 Bergen

Publications

Academic article

Show author(s) (2023). Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity. Journal of Clinical Medicine.
Show author(s) (2023). Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells. Blood. 1478-1493.

Show author(s) (2021). Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model. Cancer Biology & Therapy. 204-215.
Show author(s) (2021). Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation. International Journal of Pharmaceutics. 14 pages.

Show author(s) (2019). 8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia. Journal of Cellular Physiology. 16295-16303.

Show author(s) (2016). Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia. OncoTarget. 8105-8118.

Show author(s) (2015). 4-alkylated silver-N-heterocyclic carbene (NHC) complexes with cytotoxic effects in leukemia cells. ChemMedChem. 1522-1527.

Academic chapter/article/Conference paper

Show author(s) (2022). Modeling the Tumor Microenvironment in Patient-Derived Xenografts: Challenges and Opportunities. 16 pages.

More information in national current research information system (CRIStin)